10x Genomics
TXG
$40.49
Share price
-1.84%
Change (1 day)
-4.50%
Change (1 year)
Categories
10x Genomics (TXG) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $0.19 B
According to 10x Genomics 's latest financial reports the company's total liabilities are $0.19 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
10x Genomics - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.22 B | 10.92% |
| 2021-12-31 | $0.20 B | 5.78% |
| 2020-12-31 | $0.19 B | 2.38% |
| 2019-12-31 | $0.18 B | -46.02% |
| 2018-12-31 | $0.34 B | 83.02% |
| 2017-12-31 | $0.18 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.98 M | -98.48% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -37.22% | 🇬🇧 UK |
 Novavax NVAX | $2.43 B | 1,142.54% | 🇺🇸 USA |
 Novocure
NVCR | $0.74 B | 278.60% | Jersey |